While salary growth may range from a marginally positive to stagnant or even negative, the increment for some of the "super-specialised" profiles can go beyond 15%.
The health ministry has formed a committee to consider raising the number of drugs deemed essential and subject to price caps.
India Inc has an impressive report card to show for the first quarter of this financial year.
On the profitability front, Crisil foresees a 0.5 per cent basis points y-o-y jump in EBITDA (operating profit) margins in Q2 FY15.
According to the Icra report, earnings before interest, tax, depreciation and amortisation margin of its sample declined by 44 basis points on a YoY basis and 23 basis points on a quarter-on-quarter basis to 16.6 per cent.
Dhirubhai Ambani lived in a one-room chawl in Mumbai with his wife and children and went on to establish the Reliance Group.
In a meeting with the commerce minister, India Inc hammered Sharma on the collapse of investments, structural nature of the current account deficit and stagnant growth in agriculture.
For fast-moving consumer goods, growth is likely to be tepid.
Industry body Assocham on Monday said country's top CEOs are in favour of signing a specialised free trade agreement with the European Union in services.
Equity investors should thank cash-rich biggies such as TCS, ITC, HUL, Nestl, and Bajaj Auto for this.
India's biggest firm, Reliance Industries, has decided to cut salaries by 10 per cent in its oil and refining divisions. Several smaller companies like Kajaria Ceramics have followed suit with cuts as high as 40 per cent for those earning more than Rs 50 lakh.
No new capacity addition is planned for 2018 and capital expenditure plans are on hold
Q1 results indicate more pain ahead, as slowdown has spread to more sectors, pricing power has come down and rising interest cost is eating into profits.
A large number of large and small businesses process EU data, have customers from the EU or have access to data of EU citizens in one way or another.
The year saw 30 QIP deals raising over $5 billion and 35 IPOs.
Shares in Sun Pharmaceutical Industries fell by more than 5 per cent after the company settled a patent suit with Pfizer Inc related to its acid-reflux drug for $550 million.
The deal would involve Pfizer paying with 11.3 of its shares for each Allergan share.
The NITI Aayog's vice-chairman's charge holds ground.
US country head, key departmental heads leave; more likely to follow.
A glance back at some of the important ups and down Indian Inc faced in 2018.
Indian firms feared they would lose business if US ratified the Trans-Pacific Partnership agreement with 11 other countries.
The US provides large investment opportunities for Indian companies in software, IT services, gas exploration
India Ic has pulled up its socks to perform even better in FY16.
When it comes to key hands-on management positions, India Inc is still largely run by men.
The rise in India Inc's market value was led by asset-light firms.
Most analysts expect growth in the sales of Nifty-50 companies to decelerate, albeit marginally, in the quarter ended December compared to the corresponding period of 2013-14, with metals and real estate companies pulling down earnings.
India Inc raised various issues to increase trade flows in sectors like pharmaceuticals, banking, energy and infrastructure
Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months
Generic drugmakers cannot be sued under state law for adverse reactions to their products.
Top firms will have enough firepower to go for foreign M&As, given their balance sheet growth, say bankers.
Corporate leaders said a stable government at the Centre will help boost infrastructure spend, address agricultural distress, and encouraging employment.
New government should consider reforming taxation rules.
Motherson Sumi, Tata Steel, Jaguar Land Rover will face higher cost.
The Hinduja Group, Mukesh Ambani, Murugappa, and the Adani groups were the other gainers in the Modi regime, while Naveen Jindal and Sun Pharma groups saw the most erosion in their m-cap in the last five years, reports Krishna Kant.
Fresh investments by corporates up just 5.8% in FY17, lowest since 1992
Says operating environment for Indian corporate sector has improved during FY15
sharper-than-expected economic recovery back home, analysts say, can fuel a further rally in domestic cyclicals, industrials, and financials as global central banks continue with their easy money policy.